FDA Import Refusal UPS-5233642-9/1/1 — Glaxosmithkline

Glaxosmithkline — FEI 3003451948

The FDA refused shipment UPS-5233642-9/1/1 from Glaxosmithkline (United Kingdom) on May 22, 2014. The refused product falls under Drugs and Biologics — ORLISTAT/TETRAHYDROLIPSTATIN (ANOREXIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal details

Date
May 22, 2014
Country
United Kingdom
Product Category
Drugs and Biologics
Product Code
60RAH18 ORLISTAT/TETRAHYDROLIPSTATIN (ANOREXIC)
Charges
75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.